Nuvo Pharmaceuticals Inc MRVFF:OTCQX

RT Quote | Exchange | USD
Last | 05/16/22 EDT
0.622UNCH (UNCH)
52 week range
0.62 - 1.41
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.622
  • 52 Week High1.41
  • 52 Week High Date11/15/21
  • 52 Week Low0.62
  • 52 Week Low Date05/16/22

Key Stats

  • Market Cap7.3M
  • Shares Out11.39M
  • 10 Day Average Volume1,900
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-45.91

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.622
  • 52 Week High1.41
  • 52 Week High Date11/15/21
  • 52 Week Low0.62
  • 52 Week Low Date05/16/22
  • Market Cap7.3M
  • Shares Out11.39M
  • 10 Day Average Volume1,900
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-45.91

RATIOS/PROFITABILITY

  • EPS (TTM)-2.79
  • P/E (TTM)-0.22
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Nuvo Pharmaceuticals Inc

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Nuvo Pharmaceuticals Inc. is a Canada-based healthcare company. The Company is engaged in offering diversified portfolio of commercial products. It operates through three segments: Commercial Business, Production and Service Business and Licensing and Royalty Business. The Commercial Business segment is comprised of products commercialized by the Company in Canada. It includes products, such as Blexten, Cambia, Suvexx and NeoVisc, as well as mature products. The Production...
Robert Harris
Executive Chairman of the Board
Jesse Ledger
President, Chief Executive Officer
Mary-Jane Burkett
Chief Financial Officer, Vice President
Kelly Demerino
Interim Chief Financial Officer
Katina Loucaides
Vice President, General Counsel, Secretary
Address
6733 Mississauga Rd Suite 610
Mississauga, ON
L5N 6J5
Canada